CFDE Data Portal | Search LINC02361

	Label	Description
	LINC02361 Gene (Entity type)	ENSG00000256576 - long intergenic non-protein coding RNA 2361
	GSE182680 GSE182683 dexamethasone 7 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE173483 nutlin-3 U2OS 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680 GSE182683 dexamethasone 10 v 13 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680 GSE182683 dexamethasone 7 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 dasatinib 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 7 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE103567 EZH2 inhibition 5 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 7 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE68925 fasudil 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

LINC02361

ENSG00000256576 - long intergenic non-protein coding RNA 2361

GSE182680 GSE182683 dexamethasone 7 v 11 human up

A Gene Set from LINCS

GSE173483 nutlin-3 U2OS 1 v 0 human dn

A Gene Set from LINCS

GSE182680 GSE182683 dexamethasone 10 v 13 human up

A Gene Set from LINCS

GSE182680 GSE182683 dexamethasone 7 v 1 human up

A Gene Set from LINCS

GSE135514 dasatinib 2 v 3 human up

A Gene Set from LINCS

GSE239844 crizotinib 7 v 5 human dn

A Gene Set from LINCS

GSE103567 EZH2 inhibition 5 v 2 human up

A Gene Set from LINCS

GSE48812 sulforaphane 7 v 5 human up

A Gene Set from LINCS

GSE68925 fasudil 1 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.